Medical Innovation Exchange

Alnylam clears phase 2 test for Regeneron-partnered nephropathy med, as it looks to play catch-up against Calliditas

https://www.fiercebiotech.com/biotech/new-data-moves-alnylam-closer-phase-3-launch-regeneron-partnered-nephropathy-med

Leave a Comment

Your email address will not be published.

Leave the field below empty!